SUNUMLAR
Overview of Generic Pharmaceutical Market in Europe and Other Regions
P. Troein
VP Strategic Alliances, IMS Health EMEA
Creating the Right Environment for a Sustainable Generic Medicines Market
E. Loof
President EGA
Dynamics in the EU market
R. O'Riordan
MPSI, MMII Vice-President, Stada AG
A Wall Street Perspective on Generics
R. Silver
Senior Vice President
Specialty Pharmaceuticals Research
Assessing the Impact of Current Trends in Bioequivalance
Requirements and their Impact on the Generic Medicines Industry
S. Almeida
Medical Department Grupo Tecnimede, Portugal
Key Regulatory Developments at International and European Level and
their Impact on Business Development of Generic Companies
S. Kox
EGA Senior Director Scientific & Regulatory Affairs
Patent linkage, Bolar, Paediatric Extension and
Data Exclusivity
B. Stepniewska
Director of Regulatory Affairs, EGA
Update on the Enforcement of IP Rights
& Counterfeiting of Medicines in the EU
L. Mallo
Legal and Government Affairs Manager
IP Developments in the USA and the
Impact on Business Strategies for Generic Companies
N. Greenblum
Senior Managing Partner Greenblum & Bernstein, P.L.C.
Developed Markets Italy,Portugal,Spain
H. Carradinha
Health Economics Affairs Manager
Developing Markets Belgium - France
E. Grooten
Senior Manager EU Pharmaceutical Policy
Developed Markets Denmark, Germany,
The Netherlands, Sweden and United Kingdom
F. Bongers
Chairman Bogin NL Chair Health-Economy EGA
Eastern Europe and the Balkans
V. Afenliev
Director Business Development
CEE & Asia, ACTAVIS Group;
Chair EU Accession Committee EGA
The Russian pharmaceutical market
M. Veldanova
Managing Director Polpharma Russia
The China Challenge – A Unique & Competitive Market
M. Lotter
Current trends in generic medicines in the
Middle East: challenges and opportunities
M. Darwazah
Vice Chairman, Hikma Pharmaceuticals PLC
Golden Age is Over:
Only the Fittest can Survive
E. Bogsch
CEO Gedeon Richter
Views on the Generics Market
B. Tempest
Chief Mentor & Executive Vice Chairman of the Board
Ranbaxy Laboratories, Delhi, India
CEO panel: which way forward for
the generics medicines industry?
A. Rummelt
CEO Sandoz
Challenges of the future
J. Michal
Zentiva N.V., Chairman of the Board and CEO